# Anyonbio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anyonbio

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Latest round: Series A (May 7, 2025)
- Investors on record: 1

## About

Based in Nanjing, China, Anyonbio is  a developer of bioactive raw materials, focusing on the research and development, production and sales of upstream raw materials for in vitro diagnostic reagents. In May 2025, the company closed a series A funding from new investor Zijin Venture Capital.Anyonbio focuses on the research, development, production and sales of upstream raw materials for in vitro diagnostic reagents. Its product line covers cardiovascular, renal, diabetes, autoimmune diseases and other fields, and is suitable for detection platforms such as colloidal gold, fluorescent POCT, enzyme-linked immunosorbent and chemiluminescence.The company generates revenue by developing and providing invitro diagnostic reagents upstream raw materials.

## Funding rounds

- Series A, May 7, 2025 — Zijin Venture Capital

## Investors

- Zijin Venture Capital (https://capitalatlas.ai/funds/zijin-venture-capital) — Series A